-
Despite the safety and efficacy of the Copper T intrauterine device (ParaGard IUD, Barr Pharmaceuticals; Pomona, NY), the levonorgestrel intrauterine system (Mirena IUS, Bayer HealthCare Pharmaceuticals; Wayne, NJ), and the single-rod contraceptive implant (Implanon, Organon; Roseland, NJ), the most popular methods in the United States are oral contraceptives (OCs) and sterilization.
-
Cervical cancer, once one of the most common cancers affecting U.S. women, now ranks 14th in frequency among American women. Thanks to the introduction of the Papanicolaou (Pap) smear, the incidence of invasive cervical cancer has seen a dramatic drop. Between 1955 and 1992, U.S. cervical cancer incidence declined by 74%.
-
Thinking of new ways to reach out to patients? Planned Parenthood Columbia Willamette (PPCW) in Portland, OR, has linked services to the Internet.
-
When it comes to HIV in the United States, young people are disproportionately at risk: An estimated 50% of new HIV infections occur among those under age 25.
-
Think about the last five women who have entered your examination room. How many of them have had genital herpes simplex virus Type 2 (HSV-2) infection?
-
How can Hispanic men be reached with an HIV prevention message? It's time to spread the word. While Hispanics/Latinos comprise 15% of the U.S. population, they accounted for 17% of all new HIV infections occurring in the United States in 2006.
-
When the female condom first gained Food and Drug Administration (FDA) approval in 1993, women's health advocates hailed it as a form of female-controlled protection; however, use of the method has been underwhelming among American women since its introduction.
-
Endometriosis is a common gynecologic disorders; about 3%-10% of American reproductive-age women have endometriosis.1 Dysmenorrhea is the most common symptom reported by patients with endometriosis. What is your approach when it comes to treatment of such pain?
-
Review the list of oral contraceptives (OCs) in your current formulary. While it might seem there are several options, research scientists are focusing on development of new pills to expand women's choices.
-
How can clinicians reach at-risk teens? Take a look at the SPOT (Supporting Positive Opportunities with Teens), a one-stop, drop-in center in St. Louis aimed specifically at the 13- to 24-year age group.
